ClinicalTrials.Veeva

Menu

Anomalies of Nocturnal Gaz Exchanges in Patients With Down Syndrome

I

Institut Jerome Lejeune

Status

Completed

Conditions

Down Syndrome

Treatments

Other: Nocturnal gaz exchanges measurement

Study type

Interventional

Funder types

Other

Identifiers

NCT03903666
TriRespi

Details and patient eligibility

About

Recently, retrospective studies have shown that Down Syndrome children have a higher CO2 (carbone dioxide) sleep pressure than the general pediatric population. This increase does not seem to be always related to sleep apnea. The Investigators wish to confirm these results prospectively. The investigators hypothesize that this alveolar hypoventilation may be due to ventilatory control disorders caused by dysautonomia, but also to a decrease in the strength of the respiratory muscles within the framework of the global muscular hypotonia described in children with Down syndrome. .

Full description

47 Down syndrome patients age from 4 to 16 will be included. They will perform a medical visit at J0, then a measurement of gaz nocturnal exchanges at home within 1 month

Enrollment

48 patients

Sex

All

Ages

4 to 16 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Down syndrome patient without mosaicism
  • Age 4 to 16 years
  • Predominant French language in the living environment

Exclusion criteria

  • OAS diagnostic focused on an earlier polysomnography
  • Methylphenidate treatment started before inclusion

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

48 participants in 1 patient group

Cohort
Experimental group
Description:
47 Down syndrome patients age from 4 to 16
Treatment:
Other: Nocturnal gaz exchanges measurement

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems